Cargando…
Secondary Reporting of G6PD Deficiency on Newborn Screening
In April 2019, the Alberta Newborn Screening Program expanded to include screening for classic galactosemia using a two-tier screening approach. This approach secondarily identifies infants with glucose-6-phosphate dehydrogenase (G6PD) deficiency. The goals of this study were (i) to evaluate the per...
Autores principales: | Hoang, Stephanie C., Blumenschein, Pamela, Lilley, Margaret, Olshaski, Larissa, Bruce, Aisha, Wright, Nicola A. M., Ridsdale, Ross, Christian, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123647/ https://www.ncbi.nlm.nih.gov/pubmed/37092512 http://dx.doi.org/10.3390/ijns9020018 |
Ejemplares similares
-
The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing
por: Zhou, Janet R., et al.
Publicado: (2021) -
Newborn Screening: Current Status in Alberta, Canada
por: De Souza, Andy, et al.
Publicado: (2019) -
Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns
por: Stadem, Paul S., et al.
Publicado: (2017) -
G6PD Deficiency and Harilaou Variant in a Newborn: Intrauterine Haemolysis and Meconium Aspiration Syndrome
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2021) -
Alberta Spinal Muscular Atrophy Newborn Screening—Results from Year 1 Pilot Project
por: Niri, Farshad, et al.
Publicado: (2023)